Humana Inc

2026. okt. 9. 22:50 UTC

Humana Inc. is trading modestly higher in after-market hours, maintaining a position notably above its 20-day moving average and near the upper end of its one-month range.

2026. okt. 8. 23:01 UTC

Humana's largest Medicare Advantage contract improved to 4 stars in the 2027 ratings, reinstating eligibility for federal quality bonus payments.

2026. okt. 7. 20:01 UTC

Humana Inc. shares fell sharply despite Cantor Fitzgerald upgrading the stock to Overweight and raising its price target to $460 from $300.

2026. okt. 6. 20:07 UTC

Humana Inc. shares fell amid an investigation by Bronstein, Gewirtz & Grossman, LLC into potential corporate wrongdoing involving the company and its officers.

2026. okt. 5. 23:15 UTC

Humana Inc is seeing a modest decline in after-market trading, having retraced from an early high despite remaining above its 20-day moving average.

2026. okt. 2. 19:53 UTC

Humana Inc is trading higher, reflecting a notable increase in cumulative return since Thursday's close, reversing a trend of four consecutive lower sessions.

2026. okt. 1. 20:07 UTC

Humana Inc. shares declined amid concerns over competition despite announcing expanded Medicare Advantage offerings for 2027, marking five consecutive sessions of losses.

2026. szept. 30. 20:07 UTC

Humana Inc's shares fell sharply, following a broader market trend that has seen declines since Tuesday, remaining below the 20-day moving average.

2026. szept. 29. 19:31 UTC

Humana Inc is under investigation by Bronstein, Gewirtz & Grossman, LLC for potential corporate wrongdoing, contributing to a decline in shares during the session.

2026. szept. 28. 20:02 UTC

Humana Inc shares fell sharply after initial gains, experiencing significant volatility and declining by late afternoon, contrasting with the previous three sessions.

2026. szept. 25. 20:02 UTC

Barclays upgraded Humana Inc to Overweight, raising its price target to $515, citing a favorable outlook for Medicare Star ratings and long-term earnings potential.

2026. szept. 24. 19:25 UTC

Humana Inc. has entered a distribution agreement with TempraMed Technologies for its CenterWell Pharmacy, contributing to higher trading activity today.

2026. szept. 23. 23:31 UTC

Humana Inc. is trading modestly lower in after-market hours, moving below its 20-day moving average and near the lower end of its one-month range.

2026. szept. 22. 20:07 UTC

Humana Inc. is under investigation by Bronstein, Gewirtz & Grossman, LLC for potential corporate wrongdoing, contributing to a decline in shares during the session.

2026. szept. 21. 20:04 UTC

Humana Inc. shares fell sharply, ending at the lower end of their one-month trading range and below the 20-day moving average.

2026. szept. 16. 19:03 UTC

Humana Inc shares fell sharply, continuing a downward trend and remaining below their 20-day moving average amid ongoing market challenges.

2026. szept. 15. 22:36 UTC

Humana Inc shares are trading lower in after-market hours, continuing a trend of three consecutive daily declines amid rising Treasury yields and inflation concerns.

2026. szept. 11. 20:08 UTC

Humana Inc's shares are higher today, continuing a strong upward trend since Thursday. The stock remains above its 20-day moving average.

2026. szept. 9. 20:02 UTC

Humana Inc shares are lower amid a broader market downturn and a decline in the Managed Health Care sector. Rising crude oil prices raise inflation concerns.

2026. szept. 8. 19:46 UTC

Humana Inc. is under investigation by Bronstein, Gewirtz & Grossman, LLC, prompting investors to reassess their positions as shares trade higher since Friday.

2026. szept. 3. 20:07 UTC

Humana Inc has earned the 2026 Great Place To Work Certification, contributing to positive investor sentiment as shares advance during Thursday's session.

2026. szept. 2. 20:08 UTC

Humana Inc. shares are advancing as the company declared a quarterly cash dividend of $0.885 per share, payable on November 27, 2026.

2026. szept. 1. 20:01 UTC

Humana Inc. reaffirmed its fiscal year 2026 guidance, projecting at least $9 adjusted EPS, contributing to a positive market reaction and higher shares.

2026. aug. 27. 19:46 UTC

Humana has partnered with DaVita to enhance care for Medicare Advantage members with chronic kidney disease. Shares are advancing amid positive market sentiment.

2026. aug. 26. 20:08 UTC

Humana Inc shares are higher today amid mixed market performance and inflation data showing a slight consumer price increase in July.

2026. aug. 25. 22:02 UTC

Humana Inc shares are higher in after-market hours, rebounding from session lows despite a broader market pullback and declining consumer confidence.

2026. aug. 24. 20:06 UTC

Wolfe Research raised Humana's price target to $450, maintaining an Outperform rating. Shares are higher today, reflecting positive sentiment from the upgrade.

2026. aug. 21. 19:31 UTC

Humana Inc. shares are advancing, reflecting a broader rebound in U.S. stocks amid ongoing economic uncertainties. They pulled back earlier but regained momentum.

2026. aug. 20. 19:36 UTC

Humana Inc. appointed Dr. Shantanu Nundy as Chief Medical Officer, effective August 31. Shares are higher since Wednesday's close amid this leadership change.

2026. aug. 19. 19:51 UTC

Humana Inc. shares are lower, impacted by a significant decline in the Managed Health Care sub-sector. The company continues expanding its home-based care initiative.